Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia

dc.authorid0000-0002-4873-4391
dc.authorid0000-0002-1671-0416
dc.contributor.authorAğırbaşlı, Mehmet
dc.contributor.authorTanrikulu, Azra
dc.date.accessioned2025-05-10T19:35:43Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.2217/cer-2021-0050
dc.identifier.endpage627
dc.identifier.issn2042-6305
dc.identifier.issn2042-6313
dc.identifier.issue8
dc.identifier.pmid33887951
dc.identifier.scopusqualityQ2
dc.identifier.startpage625
dc.identifier.urihttps://doi.org/10.2217/cer-2021-0050
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8946
dc.identifier.volume10
dc.identifier.wosWOS:000642438900001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBecaris Publishing
dc.relation.ispartofJournal of Comparative Effectiveness Research
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectclinical trials
dc.subjectCOVID-19
dc.subjecttocilizumab
dc.titleTesting the efficacy of tocilizumab in patients with COVID-19 pneumonia
dc.typeEditorial

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8946.pdf
Boyut:
812.95 KB
Biçim:
Adobe Portable Document Format